Perlara

Rare disease families and researchers lack an efficient way to discover and validate treatments for ultra-rare conditions.

Perlara runs family-partnered drug repurposing and decentralized clinical development using gene-edited patient avatars and a predictive R&D engine (ArkBase) to identify promising therapies and spin out development programs.

Rare disease families, academic/clinical research centers, and biotech/pharma or impact investors developing treatments for rare diseases.